Needham Reiterates Buy on Evolus, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Serge Belanger has reiterated a Buy rating on Evolus (NASDAQ:EOLS), maintaining a $22 price target for the company's stock.
December 20, 2023 | 5:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Serge Belanger reaffirmed a Buy rating on Evolus, Inc. and kept the price target at $22, indicating a positive outlook on the stock.
The reiteration of a Buy rating by a reputable analyst like Serge Belanger can instill confidence in investors and potentially drive the stock price up in the short term. The maintained price target of $22 suggests that the analyst sees significant upside potential from the current trading price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100